Burn the ships, we’re here to stay There’s no way we could go back Now that we’ve come this far by faith Burn the ships, we’ve passed the point of no return Our life is here So let the ships burn ~Burn the Ships (lyrics) by Steven Curtis Chapman and James Isaac Elliott The phrase […]
As the importance of technology-based products and processes continues to increase, so too does the significance of patents. Unsurprisingly, therefore, patent-related disputes are becoming more common and their consequences more significant than ever. Likewise, globalization means that patent disputes must increasingly be managed on an international rather than local level. However, the lack of a […]
Coming off a recent discussion about the role patents play in fostering innovation (see: Are Patents A Driver of Innovation or Just a Tax?), it is fortunate that I’ve had a chance to read Michael Gollin’s excellent book on how intellectual property not only drives the innovation cycle but sometimes stifles it, too. Gollin’s book, […]
Next came the Patent laws. These began in England in 1624; and, in this country, with the adoption of our constitution. Before then [these?], any man might instantly use what another had invented; so that the inventor had no special advantage from his own invention. The patent system changed this; secured to the inventor, for […]
Do you know which companies the most profitable ones? Often, they’re not the best organized, the best run or even the best marketed. It turns out it is not about cutting costs, improving process efficiency and implement best practices – although those are all really noble endeavors. The real driver of profitability is the competitive […]
Early stage valuation of drug development is complicated and often considered unnecessary given that standard valuation methods can lead to negative numbers. Most early stage investors use the method known as “making it up” to value really early stage inventions. More than that, a large problem is that a company or university performing services early […]
In their book iProperty: Protecting Ideas in an Age of Global Innovation, the authors ask that we move past our old views of protecting ideas and look at what is necessary for companies to thrive in the new intense global competition today. They call this new vision the world of iProperty. The “i” in iProperty […]
“Who do you think was the country’s biggest supplier of prescription drugs in 2007? Was it Pï¬zer or Merck or Bristol-Meyers-Squib or Novartis? No. It was Teva Pharmaceuticals, a generic manufacturer.” ~ Martin Voet, The Generic Challenge: Understanding Patents, FDA & Pharmaceutical Life-Cycle Management (Second Edition). The Generic Challenge is about providing the necessary […]
Served Up Daily
Editor-in-Chief Barista Stephen Jenei is a patent attorney and Owner of Jenei LLC. When not serving up patent chat over a steaming cup of java, he's handling a diverse intellectual property practice in the biotechnology, pharmaceutical and chemical fields. More info @ Jenei LLC
